XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Equity Investment in Entasis (Details) - Entasis
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
May 03, 2021
USD ($)
shares
Jun. 30, 2021
Tranche
$ / shares
Sep. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Director
Dec. 31, 2020
USD ($)
Equity Investment            
Number of tranches | Tranche   2        
Number of investee's board members which may be designated by the Company | Director         2  
Number of the Company's Board Members Currently Serving on the Board of Investee | Director         0  
Number of the Investee's Board members | Director         6  
Equity investment ownership percentage         59.90% 51.00%
Exercise price of warrants | $ / shares   $ 2.00        
Unrealized gain from fair value changes in equity investments         $ 5.7 $ 30.5
Common stock and warrants            
Equity Investment            
Amount of securities purchase agreement     $ 12.5 $ 35.0    
Equity and long-term investments at fair value         103.7 78.0
Common stock            
Equity Investment            
Number of shares to be purchased under the securities purchase agreement | shares 10,000,000   4,672,897 14,000,000    
Amount of securities purchase agreement $ 20.0          
Equity and long-term investments at fair value         62.8 $ 46.1
Warrants            
Equity Investment            
Number of shares to be purchased under the securities purchase agreement | shares 10,000,000          
Maximum number of additional shares into which warrants may be converted under the securities purchase agreement | shares       14,000,000    
Exercise price of warrants | $ / shares     $ 2.675 $ 2.50    
Term of warrants           5 years
Equity and long-term investments at fair value         $ 40.9 $ 31.9